Enrolling by invitationPhase 2NCT06867107

A Long-term Follow-up Study for Participants That Completed the SAT-3247-CL-101 Study

Studying Duchenne muscular dystrophy

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Satellos Bioscience, Inc.
Intervention
SAT-3247(drug)
Enrollment
10 enrolled
Eligibility
18-40 years · MALE
Timeline
20252026

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT06867107 on ClinicalTrials.gov

Other trials for Duchenne muscular dystrophy

Additional recruiting or active studies for the same condition.

See all trials for Duchenne muscular dystrophy

← Back to all trials